Form 4: Martha Shadan Reports Acquisition of Dividend Equivalent Rights in LeMaitre Vascular

Director Martha Shadan reports acquiring dividend equivalent rights related to restricted stock units and performance share units in LeMaitre Vascular.

Summary

• Martha Shadan, a director of LeMaitre Vascular Inc. (LMAT), reported the acquisition of dividend equivalent rights on March 28, 2024.
• These rights are associated with restricted stock unit (RSU) and performance share unit (PSU) awards granted on December 12, 2022, and December 8, 2023.
• Specifically, 0.9644 dividend equivalent rights were acquired related to the RSU award granted on 12/12/22, 0.9644 related to the PSU award granted on 12/12/22, and 1.2345 related to the RSU award granted on 12/8/23.
• Each dividend equivalent right represents the economic equivalent of one share of LeMaitre Vascular's common stock and vests proportionately with the underlying award.
• Following the transaction, Ms. Shadan directly owns 5.9511 dividend equivalent rights related to the 12/12/22 RSU, 4.9624 related to the 12/12/22 PSU, and 1.2345 related to the 12/8/23 RSU.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to equity compensation, and does not inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the acquisition of dividend equivalent rights, which are commonly associated with equity-based compensation plans.

Stakeholder Impact

• The acquisition of dividend equivalent rights has a minimal direct impact on stakeholders, as it is related to existing equity compensation plans for company directors.

Key Dates